Stock Indices and AVXL Share Price
As a retail investor (shareholder) in Anavex Life Sciences Corp., and as a biologist who can understand to a useful degree the unique molecular and cellular science of the Anavex molecules, I read here each day’s postings, looking for useful information.
From time to time, when I think I have useful information, I’ll put it up in a new posting.
But for now, in the first quarter of 2022, I haven’t seen many useful postings. Mostly, just whinings about dislikes with the personality and performance of the CEO, connecting the share price declines to him. For most of those, I can click on to a new posting after reading just the first sentence. Haven’t missed anything of importance.
Lots of posters trying to connect the moderating share price to the factors they present. But, so far this year, the AVXL share price is controlled mostly by the broad stock indices, the DJIA, and the NASDAQ. When they edge upward (as today), the AVXL share price follows (as presently the case). Vice versa.
As a biologist understanding the profound implications of Anavex science, once it becomes therapeutically available, I want “the market” (whomever that might be) to embrace Anavex and buy lots of AVXLs. Hasn’t happened. For me, a harsh reality. The market doesn’t think like I do.
Same for those who hope that the detailed listing of the AVXL share price “catalysts,” the several meetings and events in the future will push the share price markedly higher. But, nope, no matter how good the Anavex data are, those don’t much impact the AVXL share price at all.
Frankly, right now only one thing counts. If the stock indices ascend, so will the AVXL share price. Vice versa. I’ll continue to hold my moderate AVXL position (a few thousand shares) and just wait. Very clear. The share price will not launch until positive news articles about blarcamesine appear in the general press, in The New York Times, or the evening national news broadcasts, with titles similar to this: “In Big Study, New Drug Shows Safety and Efficacy Against CNS Disease.”
In the earliest, that will be in the last half of this year; but more likely sometime in 2023. Then, the postings on this board will be exciting, even informative. Will just have to wait. The postings with the most intrinsic fun will be those put up when AVXL first trades at $1249. Some of those will be "Told ya so's."
